Queen’s Lecture 2026 by Professor Dame Molly Stevens: Designing and Translating Materials to Heal the Body and Detect Diseases Earlier.
The success of mRNA vaccines against coronavirus brought nanomedicine into the public spotlight. Now, advances in materials science and nanotechnology are opening up exciting new possibilities for how we diagnose and treat disease.
At this year’s Queen’s Lecture, Professor Dame Molly Stevens of the University of Oxford will share how her team is turning cutting-edge science into technologies with the potential to transform healthcare. Their research ranges from innovative drug-delivery systems and tiny responsive robots that can release treatments at precisely the right place and time, to nanoparticle-based diagnostic tests and new ways of detecting cancer cells more accurately.
Discover how science at the smallest scale could make a major difference to the future of medicine.
Molly Stevens
Professor Dame Molly Stevens is John Black Professor of Bionanoscience at the University of Oxford and Deputy Director of the Kavli Institute for Nanoscience Discovery. Previously, she led a highly interdisciplinary research programme at Imperial College London and is also a part-time professor at Sweden’s Karolinska Institutet.
Her pioneering research at the interface of materials science, nanotechnology and medicine has led to the creation of four spin-out companies, translating scientific discoveries into real-world applications.
The Queen's Lectures series
The Queen’s Lectures were founded by Queen Elizabeth II as a gift to the City of Berlin on the occasion of her state visit in 1965. Since 1997 the Queen’s Lecture takes place at the TU Berlin. Each year a renowned British scientist delivers a lecture on her or his area of expertise. The Queen's Lecture is a collaboration between Technical University Berlin, the British Embassy in Germany, and the British Council Germany.